{
  "id": "OPM-2025-0004-18642",
  "title": "Comment from Namratha Kandula",
  "category": "Citizen",
  "analysis": {
    "stance": "Against",
    "themes": [
      "Merit-based system concerns",
      "Due process/employee rights",
      "Politicization concerns",
      "Scientific integrity"
    ],
    "key_quote": "This rule jeopardizes the nonpartisan integrity of NIH, CDC, NSF, FDA, and related agencies, undermining evidence-based policymaking and eroding public trust.",
    "rationale": "The comment explicitly opposes the proposed rule, highlighting concerns about the politicization of federal grantmaking roles and the potential erosion of scientific integrity and merit-based processes."
  },
  "occurrence_number": 0,
  "duplicate_of": ""
}